News
-
-
PRESS RELEASE
Correction of a release from 17/08/2026, 13:05 CET/CEST - Share buyback: Announcement pursuant to Article 5 (1) (b) and (3) of Regulation (EU) No. 596/2014
Samara Asset Group plc announces share buyback and acquisition of 78 treasury shares. Total number of repurchased shares reaches 493,610. Transactions conducted via Baader Bank AG -
-
-
-
PRESS RELEASE
BioNxt Advances Cladribine Clinical Program with Completion of the Investigational Medicinal Product Dossier (IMPD) Ahead of Human Clinical Studies
BioNxt Solutions Inc. completes Investigational Medicinal Product Dossier (IMPD) for BNT23001, a sublingual cladribine oral dissolvable film for multiple sclerosis. IMPD is a significant regulatory milestone for the Company's lead drug candidate -
-
-
-